​Longevity biotech (LongBio) is the future of medicine.
Oct 18 to Oct 20

Rejuvenation biotech has already extended healthy lifespans of mice by >50%. The traditional pharma sector is slow and focused on the old model, so we're building a longevity biotech movement in the meantime.

The greatest threat to any individual, as well as society, is aging. Aging has killed almost everyone throughout history, and caused a lot of suffering on the way down. Now, the global demographic aging crisis ("Silver Tsunami") threatens to collapse the ponzi economics of legacy governments.

​Learn about the latest developments in the LongBio field, the future of gene and cell therapy, and discuss biohacking interventions that are currently in use.

Speakers include: Dr. Peter Fedichev (gero.ai), Prof. Jan Gruber (NUS Singapore), Dr. Oliver Dreesen (ASTAR Singapore), Sebastian Brunemeyer, Kamil Pabis (VitaDAO), Tristan Roberts (Co-Founder of Minicircle), ​Wang Boyang (DeSci investor) and more.

for more details:
https://lu.ma/e75x2ghn

Schedule in individual events listed.